Applied BioMath, LLC to Present at Bio-IT World Conference & Expo
Retrieved on:
Tuesday, September 14, 2021
TCGA, Biology, Biotechnology, CEO, Quantitative biology, Poster, MA, Commercial software, Pharmacology, Conference, Doctor of Philosophy, Patient, Therapeutic index, Software, LLC, Gene expression, Protalix BioTherapeutics, Applied Biosystems, Industry, Genomics, Biomarker, GDSC, Research, CLI, Pharmaceutical industry, Medical device
John Burke, PhD, Co-founder, President and CEO of Applied BioMath will present "Applied BioMath Assess - An Early Feasibility Assessment Tool for Biotherapeutics" within the Software Applications and Services track on Tuesday, September 21st at 10:30 a.m.
Key Points:
- John Burke, PhD, Co-founder, President and CEO of Applied BioMath will present "Applied BioMath Assess - An Early Feasibility Assessment Tool for Biotherapeutics" within the Software Applications and Services track on Tuesday, September 21st at 10:30 a.m.
- In this presentation, Dr. Burke will demonstrate Applied BioMath Assess*, an interactive, web-based application that helps assess the difficulties and risks in developing a therapeutic very early-on.
- Dr. Burke will explain how Applied BioMath Assess can help project teams answer questions such as:
How does affinity impact target inhibition? - Applied BioMath and the Applied BioMath logo are registered trademarks of Applied BioMath, LLC.